Targeting

Lanqing Zhao, Yu Chen, Xiaoxu Ding, Hongxi Li, Jinwei Li

Abstract read

In one paragraph

Article in Journal of pharmaceutical analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it

0cells of the map it votes in

6citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

Analytical Methods and Application of Single-Cell and Single-Nucleus Transcriptomics in the Study of Ischemic Stroke.Biomolecules · 2026
Review
Role of Activating Transcription Factor 4 in Metabolic, Neurologic, and Ocular Diseases.Cells · 2026
Review
Exploring the molecular mechanism of dexmedetomidine in alleviating blood-brain barrier disruption in rats with cerebral ischemia reperfusion injury based on network pharmacology.Frontiers in molecular neuroscience · 2026
Article
Single-cell and single-nucleus transcriptomics in ischemic stroke: cellular mechanisms and therapeutic implications.Frontiers in neurology · 2026
Review
The multi-target protective effects of quercetin in cerebrovascular diseases: a dietary strategy for endothelial repair and neuroprotection.Frontiers in nutrition · 2026
Review
Insights gained from single-cell sequencing analysis of ischemic stroke.Frontiers in cell and developmental biology · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lanqing ZhaoDepartment of Sleep Medicine Center, Shengjing Hospital of China Medical University, Shenyang, 110004, China.

Yu ChenDepartment of Otorhinolaryngology Head and Neck, Shengjing Hospital of China Medical University, Shenyang, 110004, China.

Xiaoxu DingDepartment of Otorhinolaryngology Head and Neck, Shengjing Hospital of China Medical University, Shenyang, 110004, China.

Hongxi LiDepartment of Pain Management, Shengjing Hospital of China Medical University, Shenyang, 110004, China.

Jinwei LiDepartment of Neurology and Stroke Center, The First Affiliated Hospital of China Medical University, China Medical University, 110001, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the neuroprotective potential of extracellular vesicles (EVs) delivering quercetin-3-

Indexed as

Atf4Cerebral ischemia-reperfusion injuryExtracellular vesiclesNeuroprotectionOxidative stressQuercetin-3-O-β-d-glucuronic acid

Identifiers

PMID41079784

DOI10.1016/j.jpha.2025.101312

PMCPMC12509756

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.